Guixiang Liao

1.4k total citations
43 papers, 1.0k citations indexed

About

Guixiang Liao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Guixiang Liao has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 11 papers in Genetics. Recurrent topics in Guixiang Liao's work include Brain Metastases and Treatment (13 papers), Glioma Diagnosis and Treatment (10 papers) and Gastric Cancer Management and Outcomes (6 papers). Guixiang Liao is often cited by papers focused on Brain Metastases and Treatment (13 papers), Glioma Diagnosis and Treatment (10 papers) and Gastric Cancer Management and Outcomes (6 papers). Guixiang Liao collaborates with scholars based in China, Hong Kong and Canada. Guixiang Liao's co-authors include Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Xianming Li, Rong Li, Yawei Yuan, Shasha Du, Jie Lin, Zhihong Zhao and Haijun Deng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Guixiang Liao

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guixiang Liao China 20 534 441 233 187 139 43 1.0k
Rajesh Bandekar United States 19 405 0.8× 377 0.9× 273 1.2× 262 1.4× 46 0.3× 48 1.3k
Kuo-Ting Chang Taiwan 12 328 0.6× 442 1.0× 85 0.4× 213 1.1× 72 0.5× 22 749
Manabu Yamamoto Japan 19 417 0.8× 456 1.0× 422 1.8× 212 1.1× 25 0.2× 109 1.2k
Hisatoshi Nakagawara Japan 21 517 1.0× 341 0.8× 485 2.1× 211 1.1× 31 0.2× 68 1.1k
Verena De Angelis Italy 19 582 1.1× 402 0.9× 516 2.2× 270 1.4× 56 0.4× 58 1.5k
Hironori Hayashi Japan 22 442 0.8× 235 0.5× 341 1.5× 305 1.6× 24 0.2× 97 1.2k
Yuki Kiyozumi Japan 19 542 1.0× 354 0.8× 462 2.0× 258 1.4× 20 0.1× 45 1.2k
Hacı Mehmet Türk Türkiye 14 265 0.5× 227 0.5× 163 0.7× 128 0.7× 38 0.3× 75 708
Ana Custodio Spain 21 705 1.3× 306 0.7× 107 0.5× 301 1.6× 90 0.6× 75 1.2k

Countries citing papers authored by Guixiang Liao

Since Specialization
Citations

This map shows the geographic impact of Guixiang Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixiang Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixiang Liao more than expected).

Fields of papers citing papers by Guixiang Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guixiang Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixiang Liao. The network helps show where Guixiang Liao may publish in the future.

Co-authorship network of co-authors of Guixiang Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Guixiang Liao. A scholar is included among the top collaborators of Guixiang Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guixiang Liao. Guixiang Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Guixiang, et al.. (2022). The evolving role of radiation therapy as treatment for liver metastases. SHILAP Revista de lepidopterología. 2(3). 183–187. 8 indexed citations
2.
Liao, Guixiang, Muhammad Khan, Zhihong Zhao, et al.. (2021). Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review. Frontiers in Oncology. 11. 593449–593449. 34 indexed citations
3.
Khan, Muhammad, et al.. (2021). Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study. International Journal of General Medicine. Volume 14. 8903–8918. 5 indexed citations
4.
Liao, Guixiang, et al.. (2021). Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 774131–774131. 18 indexed citations
5.
Khan, Muhammad, Zhihong Zhao, Sumbal Arooj, & Guixiang Liao. (2021). Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis. BMC Cancer. 21(1). 167–167. 41 indexed citations
6.
Liao, Guixiang, Yuting Qian, Sumbal Arooj, et al.. (2021). Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study. Frontiers in Oncology. 11. 742971–742971. 5 indexed citations
7.
Khan, Muhammad, Zhihong Zhao, Sumbal Arooj, Tao Zheng, & Guixiang Liao. (2020). Lapatinib Plus Local Radiation Therapy for Brain Metastases From HER-2 Positive Breast Cancer Patients and Role of Trastuzumab: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 10. 576926–576926. 28 indexed citations
8.
Khan, Muhammad, et al.. (2020). Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy. Frontiers in Immunology. 11. 587460–587460. 110 indexed citations
9.
Khan, Muhammad, Zhihong Zhao, Sumbal Arooj, & Guixiang Liao. (2020). Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma. Frontiers in Oncology. 10. 1246–1246. 17 indexed citations
10.
Liao, Guixiang, et al.. (2019). Can Prognostic Nutritional Index be a Prediction Factor in Esophageal Cancer?: A Meta-Analysis. Nutrition and Cancer. 72(2). 187–193. 35 indexed citations
11.
12.
Khan, Muhammad, Jie Lin, Guixiang Liao, et al.. (2019). ALK Inhibitors in the Treatment of ALK Positive NSCLC. Frontiers in Oncology. 8. 557–557. 62 indexed citations
13.
Khan, Muhammad, Jie Lin, Guixiang Liao, et al.. (2019). Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors. Frontiers in Oncology. 9. 205–205. 16 indexed citations
14.
Khan, Muhammad, Jie Lin, Guixiang Liao, et al.. (2018). Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer. Medicine. 97(33). e11936–e11936. 83 indexed citations
15.
Li, Rong, Guixiang Liao, Baiyao Wang, et al.. (2017). Ionizing Radiation Blocks Hair Cell Regeneration in Zebrafish Lateral Line Neuromasts by Preventing Wnt Signaling. Molecular Neurobiology. 55(2). 1639–1651. 5 indexed citations
16.
Liao, Guixiang, et al.. (2016). Sodium valproate prevents radiation-induced injury in hippocampal neurons via activation of the Nrf2/HO-1 pathway. Neuroscience. 331. 40–51. 31 indexed citations
17.
Liao, Guixiang, Yanbing Li, Zhihong Zhao, et al.. (2016). Robotic-assisted surgery versus open surgery in the treatment of rectal cancer: the current evidence. Scientific Reports. 6(1). 26981–26981. 28 indexed citations
18.
Yao, Qiwei, Rong Zheng, Guozhu Xie, et al.. (2015). Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy. Scientific Reports. 5(1). 9119–9119. 9 indexed citations
19.
Zhao, Zhihong, et al.. (2014). Prognostic Value of Carbonic Anhydrase IX Immunohistochemical Expression in Renal Cell Carcinoma: A Meta-Analysis of the Literature. PLoS ONE. 9(11). e114096–e114096. 31 indexed citations
20.
Liao, Guixiang. (2008). Clinical Observation of Treating Debilitating with Acanthopanax senticosus Capsule. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajesh Bandekar Breakdown of academic impact, for papers by Kuo-Ting Chang Breakdown of academic impact, for papers by Manabu Yamamoto Breakdown of academic impact, for papers by Hisatoshi Nakagawara Breakdown of academic impact, for papers by Verena De Angelis Breakdown of academic impact, for papers by Hironori Hayashi Breakdown of academic impact, for papers by Yuki Kiyozumi Breakdown of academic impact, for papers by Hacı Mehmet Türk Breakdown of academic impact, for papers by Ana Custodio
Rankless by CCL
2026